Product Information
OXCARBAZEPINE ER 300 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $4.5025 per EA under NDC 50742061201. Its NADAC has been published 60 times since Jul 2, 2025.
FDA first approved this application on Nov 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Oxcarbazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742061201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215796FDA Approved
11/22/2024
TE Code
AB
On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE ER 300 MG TABLET has been published 60 times since Jul 2, 2025, and over the history we have for it it has declined 44.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5025 per EA |
|---|---|
| All-time high | $9.0124 (Jan 14, 2026) |
| All-time low | $4.2889 (Jul 22, 2026) |
| 52-week high | $9.0124 |
| 52-week low | $4.2889 |
| Median price | $8.1177 |
| Average price | $7.2634 |
| Largest weekly change | -13.7% (Apr 22, 2026) |
| Weeks tracked | 60 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE ER 300 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $4.5025 per EA (NDC 50742061201), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE ER 300 MG TABLET has declined 44.2%. It has been tracked across 60 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE ER 300 MG TABLET?
Since Jul 2, 2025, the NADAC for OXCARBAZEPINE ER 300 MG TABLET has ranged from a low of $4.2889 (Jul 22, 2026) to a high of $9.0124 (Jan 14, 2026), with a median of $8.1177 per EA.
Are there cheaper alternatives to OXCARBAZEPINE ER 300 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1637 per EA — about 96% below OXCARBAZEPINE ER 300 MG TABLET.
Who manufactures OXCARBAZEPINE ER 300 MG TABLET?
OXCARBAZEPINE ER 300 MG TABLET (NDC 50742061201) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.